|
U.S. Lawmakers Asked to Better Monitor, Protect Overseas Patents
Congress and the U.S. Trade Representative need to do more to protect American biopharma patents abroad, an intellectual property (IP) expert tells Congress.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives